SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-062675
Filing Date
2018-11-30
Accepted
2018-11-30 17:26:24
Documents
1
Period of Report
2018-11-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv507899_4.html 4  
1 OWNERSHIP DOCUMENT tv507899_4.xml 4 4414
  Complete submission text file 0001144204-18-062675.txt   5935
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 781-652-4507
Hunter Robyn (Reporting) CIK: 0001713932 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 181212093